Sort
51,593 grants matching “hepatitis”
Integrated approaches to close the loop in type 1 diabetes
$634,997Ananda Basu · University Of Virginia · R01 · FY2018 · DK
Colorado Center of Childhood Liver Disease Research Network
$634,997Ronald J Sokol · University Of Colorado Denver · U01 · FY2020 · DK
Ontogeny of drug transport
$634,959Bhagwat Prasad · Washington State University · R01 · FY2022 · HD
Mechanisms of Therapy and Model Development in Hepatitis C and Liver Diseases
$634,937T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK
Interstitial pressure sensor to detect fluid status
$634,926Robert Schwartz · Nxt Biomedical, Llc · R43 · FY2023 · HL
Role of the Gut Microbiota in Abdominal Aortic Aneurysm
$634,924Albert Phillip Owens III · University Of Cincinnati · R01 · FY2022 · HL
Bio-Psycho-Social Drivers of Disparities in Liver Disease Progression among Korean Americans with Hepatitis B Infection
$634,924Hee-Soon Juon · Thomas Jefferson University · R01 · FY2023 · DK
Role of the Gut Microbiota in Abdominal Aortic Aneurysm
$634,924Albert Phillip Owens III · University Of Cincinnati · R01 · FY2023 · HL
Novel Determinants for Progression of Non-Alcoholic Fatty Liver Disease to Hepatocellular Carcinoma and Other Health Outcomes
$634,830Jian-Min Yuan · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
Longitudinal Study of Early NAFLD Progression and the Gut Microbiome in Asian Americans, Native Hawaiians and Whites
$634,776Unhee Lim · University Of Hawaii At Manoa · R01 · FY2025 · MD
Genomics and pharmacodynamics of statin-related rhabdomyolysis
$634,759Bruce M Psaty · University Of Washington · R01 · FY2014 · HL
Zinc for HIV Disease among Alcohol Users -An RCT in the Russia ARCH Cohort
$634,743Jeffrey H Samet · Boston Medical Center · U01 · FY2012 · AA
The altered lipid and protein metabolism of pediatric patients with HIV infection
$634,722Farook Jahoor · Baylor College Of Medicine · R01 · FY2009 · HD
Genetic determinants of NAFLD severity and progression
$634,699Johanna K Distefano · Translational Genomics Research Inst · R01 · FY2012 · DK
Preservation of DCD Allograft Integrity for Liver Transplantation
$634,680Sylvester M Black · Ohio State University · R01 · FY2020 · DK
CSDE1 as a Post Transcriptional Regulator of the LDLR
$634,589John S Chorba · University Of California, San Francisco · R01 · FY2021 · HL
Genetic Epidemiology of Complex Traits
$634,582Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2016 · HG
Predicting outcomes in nonalcoholic steatohepatitis with advanced fibrosis
$634,480Arun J Sanyal · Virginia Commonwealth University · R01 · FY2022 · DK
FLORIDA ADULT VIRAL HEPATITIS PREVENTION & SURVEILLANCE PROJECY=T
$634,476Philip Reichert · Florida State Department Of Health · U51 · FY2015 · PS
Implications of HIV in Low HCV Clearance in Chinese IDUs
$634,422Johns Hopkins University · R01 · FY2004 · DA
Addressing Hepatitis C and Hepatocellular Carcinoma: Current and Future Epidemics
$634,335Holly C. Hagan · New York University · R01 · FY2013 · DA
Quantitative Multimodal Image Guidance for Improved Liver Cancer Treatment
$634,276James S Duncan · Yale University · R01 · FY2018 · CA
Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis
$634,271Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2013 · CA
Roles for virus-derived circular RNAs during RNA virus infections
$634,198Peter Sarnow · Stanford University · R56 · FY2025 · AI
Implications of HIV in Low HCV Clearance in Chinese IDUs
$634,171Johns Hopkins University · R01 · FY2003 · DA